Literature DB >> 15313908

Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity.

Nils Cordes1.   

Abstract

Integrin-linked kinase (ILK), bound to the cytoplasmic tails of integrin beta1, beta2, and beta3, is thought to signal through AKT and glycogen synthase kinase-3beta (GSK-3beta) for survival and proliferation regulation. To determine the role of ILK in the cellular radiation response, stably transfected A549 lung cancer cells overexpressing either wild-type (ILK-wk) or hyperactive ILK (ILK-hk) were studied for survival, signaling, proliferation, and examined in immunofluorescence and adhesion assays. Strong radiosensitization was observed in ILK-hk in contrast to ILK-wk mutants and empty vector controls. ILK small interfering RNA transfections showed radioresistance similar to irradiation on fibronectin. AKT, GSK-3beta-cyclin D1, mitogen-activated protein kinase kinase 1/2-mitogen-activated protein kinase, and c-Jun NH2-terminal kinase signaling was dysregulated in irradiated ILK-hk mutants. Immunofluorescence stainings of ILK-hk cells indicated disturbed ILK and paxillin membrane localization with concomitant decrease in focal adhesions. Profound ILK-hk-dependent changes in morphology were characterized by spindle-like cell shape, cell size reduction, increased cell protrusions, strong formation of membranous f-actin rings, and significantly reduced adhesion to matrix proteins. Additionally, ILK-wk and ILK-hk overexpression impaired beta1-integrin clustering and protein Tyr-phosphorylation. Taken together, the data provide evidence that ILK signaling modulates the cellular radiation response involving diverse signaling pathways and through changes in f-actin-based processes such as focal adhesion formation, cell adhesion, and spreading. Identification of ILK and its signaling partners as potential targets for tumor radiosensitization might promote innovative anticancer strategies by providing insight into the mechanism of cell adhesion-mediated radioresistance, oncogenic transformation, and tumor growth and spread.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313908     DOI: 10.1158/0008-5472.CAN-04-1056

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

Review 1.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 2.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  c-Jun N-terminal kinase is involved in the regulation of proliferation and apoptosis by integrin-linked kinase in human retinoblastoma cells.

Authors:  Zhen Chen; Anhuai Yang; Chong Xu; Yiqiao Xing; Wenrong Gong; Junping Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-14       Impact factor: 3.117

4.  Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis.

Authors:  Dan Zhao; Xiu-Fa Tang; Kai Yang; Ji-Yuan Liu; Xiang-Rui Ma
Journal:  Clin Exp Metastasis       Date:  2012-05-26       Impact factor: 5.150

5.  The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase.

Authors:  Peijun Liu; Jining Lu; Wellington V Cardoso; Cyrus Vaziri
Journal:  Mol Biol Cell       Date:  2007-11-07       Impact factor: 4.138

6.  Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase.

Authors:  Shouwei Han; Xiaojuan Sun; Jeffrey D Ritzenthaler; Jesse Roman
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

7.  Integrin-linked kinase is involved in cocaine sensitization by regulating PSD-95 and synapsin I expression and GluR1 Ser845 phosphorylation.

Authors:  Qiang Chen; Xiongzhao Zhu; Yu Zhang; William C Wetsel; Tong H Lee; Xiuwu Zhang
Journal:  J Mol Neurosci       Date:  2009-07-24       Impact factor: 3.444

8.  Expression of integrin-linked kinase is increased in differentiated cells.

Authors:  Michael Haase; Christine C Gmach; Iris Eke; Stephanie Hehlgans; Gustavo B Baretton; Nils Cordes
Journal:  J Histochem Cytochem       Date:  2008-05-27       Impact factor: 2.479

9.  JNK1 determines the oncogenic or tumor-suppressive activity of the integrin-linked kinase in human rhabdomyosarcoma.

Authors:  Adam D Durbin; Gino R Somers; Michael Forrester; Malgorzata Pienkowska; Gregory E Hannigan; David Malkin
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

10.  The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck.

Authors:  Iris Eke; Franziska Leonhardt; Katja Storch; Stephanie Hehlgans; Nils Cordes
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.